Intumo Therapeutics, Inc.
Clinical trials sponsored by Intumo Therapeutics, Inc., explained in plain language.
-
Needle injection trial aims to zap liver tumors without surgery
Disease control Recruiting nowThis study is testing whether a new injection called INT001 can safely destroy liver tumors in adults who aren't candidates for surgery. Doctors will use imaging to guide a needle into the tumor and inject INT001 directly, then monitor patients for 90 days to see if the tumor is …
Phase: NA • Sponsor: inTumo Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New fluid treatment aims to ease Men's nighttime bathroom trips
Symptom relief Recruiting nowThis study is testing whether a treatment called INTUPRO can improve urinary symptoms and quality of life for men with an enlarged prostate (BPH). About 30 men will receive the treatment and then be checked at 1 and 3 months to see if it helps with problems like weak urine flow, …
Phase: NA • Sponsor: inTumo Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC